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Summary
 
Ceramides deriving from sphingomyelin hydrolysis are important mediators of apoptotic signals
originating from Fas (APO-1/CD95). However, definitive evidence for the role played by in-
dividual sphingomyelinases is still lacking. We have analyzed lymphoblastoid cell lines derived
from patients affected by Niemann Pick disease (NPD), an autosomal recessive disorder caused
by loss-of-function mutations within the acidic sphingomyelinase (ASM) gene. NPD lympho-
blasts, which display normal neutral sphingomyelinase activity, fail to activate ASM in response
to Fas cross-linking, unlike normal lymphoblasts. NPD lymphoblasts also fail to accumulate
GD3 ganglioside, a downstream mediator of ceramide-induced cell death (De Maria, R., L.
Lenti, F. Malisan, F. D’Agostino, B. Tomassini, A. Zeuner, M.R. Rippo, R. Testi. 1997. 
 
Sci-
ence.
 
 277:1652–1655), and display a substantially inefficient apoptosis after Fas cross-linking. In-
efficient apoptosis is due to lack of ASM activity, because proximal signaling from Fas in NPD
lymphoblasts is not impaired and apoptosis can be efficiently triggered by passing the ASM de-
fect with exogenous ceramides. Moreover, mannose receptor–mediated transfer of ASM into
NPD lymphoblasts rescues their ability to transiently activate ASM, accumulate GD3, and rap-
idly undergo apoptosis after Fas cross-linking. These results provide definitive genetic evidence
for the role of ASM in the progression of apoptotic signals originating from Fas.
 
C
 
ross-linking of the surface receptor Fas (APO-1/
CD95) triggers apoptotic cell death in a variety of cell
types (1, 2). Defining the effectors that are involved in the
propagation of apoptotic signals originating from Fas bears
promises for the possibility to modulate apoptosis in dis-
eases where accelerated Fas-dependent cell death occurs.
Several early events concur in setting the irreversible
commitment to cell death after Fas cross-linking. Seconds
after receptor engagement, caspase 8 (FLICE/MACH-1/
MCH5), a member of the ICE/CED-3 family of cysteine
proteases, is recruited to the receptor “death domain” via
the adaptor molecule FADD/MORT1, and is activated (3,
4). Sequential triggering of downstream caspases leads to
the hydrolysis of crucial protein substrates within the fol-
lowing hours, contributing to apoptotic cell shape changes
(5, 6). Concomitantly, a lipid pathway is initiated by death
domain–dependent early caspases (7) and involves the se-
quential activation of phosphatidylcholine-specific phospholi-
pase C (PC-PLC) and membrane-associated acidic sphin-
gomyelinase (ASM) (8-10). ASM generates transient ceramide
accumulation in acidic cellular compartments within min-
utes. This is followed by enhanced activity of GD3 syn-
thase with accumulation of GD3 ganglioside in the Golgi
and early depolarization of the inner mitochondrial mem-
brane within the first 2 h after Fas cross-linking (11).
Mitochondrial damage with induction of membrane
permeability transition crucially contributes to the apop-
totic program with the release of diffusible factors responsible
for the activation of downstream caspases (12–14). More
ceramide is then formed by the action of caspase-dependent
cytosolic neutral sphingomyelinase (NSM), accumulates
beginning within a few hours after Fas cross-linking, and
persists throughout the entire apoptotic process (15, 16).
Although ceramides act as important intracellular media-
tors of apoptotic signals, the relative contribution of indi-
vidual sphingomyelinases in the apoptotic program is still
unclear (17). Here we used lymphoid cell lines derived
 
1
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phatidylcholine-specific phospholipase C.
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from patients affected by Niemann Pick disease (NPD)
type B, a genetic disorder characterized by deficiency of
ASM (18) but not NSM, as a unique model to assess the
role of ASM in Fas-mediated apoptosis of human lympho-
cytes.
 
Materials and Methods
 
Cells and Reagents.
 
EBV-transformed lymphoblasts derived
from type B NPD patients (19) or from normal controls were
grown in a mixture of RPMI and DMEM media (1:1, vol/vol)
supplemented with 15% FCS (Hyclone Laboratories, Hyclone,
UT). The parental Chinese hamster ovary (CHO) cell line and
the CHO-18 clone overexpressing human ASM were grown in
DMEM supplemented with 10% FCS. ASM-enriched superna-
tant from the CHO-18 line was recovered after 3 d of culture in
35-mm dishes and stored at 
 
2
 
20
 
8
 
C until use (20).
Anti-Fas mAb (CH-11 clone) was from Upstate Biotechnol-
ogy Inc. (Lake Placid, NY). C
 
6
 
-ceramide (
 
N
 
-exanoyl-
 
d
 
-sphyn-
gosine), GD3 ganglioside, and 
 
d
 
-mannose-6-phosphate (M6P)
were from Sigma Chemical Co. (St. Louis, MO). C
 
2
 
-ceramide and
C
 
2
 
-dihydroceramide were from Biomol (Plymouth Meeting, PA).
[
 
N
 
-methyl-
 
14
 
C]sphingomyelin and L-3-phosphatidyl[
 
N
 
-methyl-
14C]choline,1,2-dipalmitoyl, used for in vitro acidic sphin-
gomyelinase and PC-PLC assays, respectively, were from Amer-
sham International (Little Chalfont, Buckinghamshire, UK). The
specific PC-PLC inhibitor D609 (10) was from Kamiya (Thousand
Oaks, CA).
 
Acid and Neutral Sphingomyelinase Assay. Methyl
 
-
 
14
 
C–labeled
sphingomyelin (Amersham International; specific activity 56
mCi/mmol) was diluted in ethanol containing cold sphingomye-
lin to a final specific activity of 1 mCi/mmol. The substrate mix-
ture was evaporated, resuspended in ASM or NSM buffer, soni-
cated to form micelles, and placed on ice until use. Cells were
washed twice with ice-cold PBS and dissolved in 0.2% Triton
X-100. After 10 min on ice, cell lysates were centrifuged for 5
min at 2,000 rpm, and supernatants were sonicated for 10 min in
an ice-cold ultrasound bath. Next, 15 
 
m
 
l of each sample were in-
cubated for 2 h at 37
 
8
 
C with 15 
 
m
 
l of the sphingomyelin mixture
resuspended in ASM buffer (250 mM sodium acetate, pH 5.2,
and 0.2% Triton X-100), or in NSM buffer (40 mM Hepes, pH
7.4, 5 mM MgCl
 
2
 
, and 0.2% Triton X-100) to determine ASM
or NSM activity, respectively. Radioactive phosphocholine
(PCho) produced from 
 
14
 
C-labeled sphingomyelin was extracted
with 200 
 
m
 
l of chloroform/methanol (1:1 vol/vol) and 90 
 
m
 
l of
water. The amount of [
 
14
 
C]PCho produced was quantified by
liquid scintillation counting. ASM and NSM activities were ex-
pressed as pmol of SM hydrolysed by 10
 
6
 
 cells per hour.
 
Measurement of PC-PLC Activity.
 
Aliquots of 10
 
7
 
 cells were
resuspended in 1 ml RPMI medium supplemented with 10%
FCS, pretreated for 30 min with zVAD-fmk, and stimulated for
the indicated times with anti-Fas mAb (500 ng/ml). Stimulation
was stopped by immersion of samples in methanol and dry ice
(
 
2
 
70
 
8
 
C) for 10 sec followed by centrifugation at 4
 
8
 
C. Pellets
were dissolved in 300 
 
m
 
l of 0.01% Triton X-100 and then were
sonicated. 16 
 
m
 
l of lysate were incubated at 37
 
8
 
C for 2 h in PC-
PLC buffer (50 mM Tris-HCl, pH 7.3, 6.3 mM CaCl
 
2
 
, 0.13 
 
m
 
g/
ml BSA, 0.15 M ammonium sulfate, and 
 
l
 
-3-phosphatidyl[
 
N
 
-
methyl-
 
14
 
C]choline, 50 nCi) in 80 
 
m
 
l of total volume. The reac-
tion was stopped and the lipids were extracted by adding CHCl
 
3
 
:
CH
 
3
 
OH (1:2, vol/vol; 180 
 
m
 
l), 0.9% NaCl (60 
 
m
 
l), and CHCl
 
3
 
(60 
 
m
 
l). The aqueous and organic phases containing [
 
14
 
C]PCho
and [
 
14
 
C]PC, respectively, were separated and quantitated by liq-
uid scintillation. PC-PLC activation was expressed as picomoles
of PCho released per 10
 
7
 
 cells. 
 
Immunofluorescence, DNA Labeling, and Flow Cytometry Analy-
sis.
 
For surface staining, cells were incubated for 30 min at 4
 
8
 
C
with saturating amounts of PE-conjugated control IgG
 
1
 
 or anti-
Fas antibody (DX2; PharMingen, San Diego, CA), and analyzed
by flow cytometry. The cell pellet was gently resuspended in hy-
potonic fluorochrome solution (propidium iodide 50 
 
m
 
g/ml
[Sigma Chemical Co.] in 0.1% sodium citrate plus 0.1% Triton
X-100), kept overnight at 4
 
8
 
C in the dark until flow cytometry
analysis. Percentage of apoptotic cells was determined by evaluat-
ing the number of hypodiploid nuclei.
 
Detection of GD3 Ganglioside Accumulation.
 
Cells were suspended
in ice-cold deionized water, disrupted by two cycles of freezing
and thawing, and extracted twice in water/methanol/chloroform (3:
8:4 vol/vol/vol). Samples were then extracted from the upper-
phase of the partition and dried by a rotary evaporator, and salts
and other nonlipid contaminants were removed by chromatogra-
phy over Supelclean L-C18 columns (Supelco, Bellefonte, PA).
The eluted gangliosides were spotted on aluminium-backed silica
gel 60 high performance thin layer chromatography (HPTLC)
plates (Merck, Darmstadt, Germany), developed in chloroform/
methanol/0.25% aqueous KCl (5:4:1 vol/vol/vol). After warm air
drying, plates were treated with 0.5% polyisobutylmetacrylate in
hexane for 90 s, incubated for 10 min with 2% BSA in PBS and
Figure 1. NPD lymphoblasts have normal Fas expression and NSM ac-
tivity, but display a very low ASM activity. Cell lysates from normal (open
columns) and NPD (shaded columns) lymphoblasts were incubated with ra-
dioactive SM in the presence of NSM (A) or ASM (B) reaction buffer.
Data are expressed as mean 6 SD from five different experiments. (C)
Flow cytometry analysis of normal and NPD lymphoblasts stained with
anti-Fas PE or with control isotype-matched IgG. Two NPD and three
normal lymphoblastoid cell lines gave comparable results. 
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for 1 h with R24 anti-GD3 antibody (mouse monoclonal IgG
 
3
 
,
provided by Dr. L.J. Old, Ludwig Institute, New York), and
washed three times. Then plates were treated with horseradish
peroxidase–conjugated goat anti–mouse IgG, and GD3 was visu-
alized by immunoperoxidase staining.
 
Results and Discussion
 
The ASM Defect Impairs the Efficiency of Fas-induced Apop-
tosis.
 
Lymphoblastoid cell lines, derived from peripheral
blood lymphocytes of patients affected by NPD, were as-
sessed for basal levels of both NSM and ASM. As shown in
Fig. 1, 
 
A
 
 and 
 
B
 
, NPD lymphoblasts and lymphoblasts de-
rived from normal donors display comparable NSM activ-
ity, but ASM activity in NPD lymphoblasts is less than 10%
of normal levels. Expression of Fas at the cell surface is sim-
ilar between NPD and normal lymphoblasts (Fig. 1 
 
C
 
).
This cellular system therefore represents a powerful model
in which to assess the relevance of ASM in Fas-mediated
apoptosis of human lymphoid cells.
The ability of anti-Fas mAbs to induce apoptosis in NPD
lymphoblasts was investigated. Fig. 2 shows that cross-link-
ing of Fas induces apoptosis very inefficiently in NPD lym-
phoblasts. In fact, the kinetics of both cytosolic changes
(data not shown) and nuclear DNA loss (Fig. 2, 
 
top
 
) is dra-
matically delayed compared to normal lymphoblasts. Mito-
chondrial changes are also delayed in NPD lymphoblasts
after Fas cross-linking (Rippo, M.R., et al., manuscript
submitted for publication). In contrast, cell permeable C
 
2
 
-
ceramide rapidly induces apoptosis in NPD lymphoblasts
(Fig. 2, 
 
bottom
 
), suggesting that bypassing the genetic defect
with exogenous ceramides is sufficient to effectively trigger
the apoptotic program.
The inefficiency of Fas cross-linking to induce apoptosis
in NPD lymphoblasts could be due to impaired signal gen-
eration. To rule out this possibility, we investigated the
ability of Fas-derived signals to induce PC-PLC activity, as
this is immediately upstream from and required for ASM
triggering. Fas cross-linking resulted in levels of PC-PLC
induction comparable to those observed in normal lym-
phoblasts (Fig. 3, 
 
A
 
 and 
 
B
 
), suggesting that early signal gen-
eration from Fas occurs correctly in ASM-deficient cells.
We recently showed that the synthesis and transient ac-
cumulation of GD3 ganglioside is required for the progres-
sion of apoptotic signals induced by Fas cross-linking and
ceramides (11). The ability of Fas-delivered signals to in-
duce GD3 accumulation was therefore investigated in
Figure 2. Sensitivity to Fas stimulation and exposure to synthetic cer-
amides. Normal and NPD lymphoblasts were incubated with 200 ng/ml
of anti-Fas or control IgM (top), or with 25 mM C2-ceramide or C2-dihy-
droceramide (bottom). At different time points, the number of apoptotic
cells was evaluated by propidium iodide staining and flow cytometry anal-
ysis. Results are expressed as mean 6 SD of six different experiments.
Figure 3. Fas stimulation in NPD lymphoblasts efficiently induces PC-
PLC activity, but fails to generate GD3 ganglioside accumulation. Cell
extracts from 107 normal (A) and NPD (B) lymphoblasts treated for 15
min with control IgM or 500 ng/ml anti-Fas mAb, preceded or not by
preincubation with 50 mg/ml D609 for 30 min, were reacted with radio-
labeled PC, and the released PCho was quantitated. (C) 107 normal and
NPD lymphoblasts were left untreated or were stimulated with 100 mM
C6-ceramide (cer) or 500 ng/ml anti-Fas for 5 or 15 min, respectively.
Then polar lipids were extracted and run on HPTLC plates along with
GD3 standard (st), and GD3 was detected by anti-GD3 immunostaining.
Four experiments gave comparable results. 
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NPD lymphoblasts. Fig. 3 
 
C
 
 shows that, unlike normal
lymphoblasts, NPD lymphoblasts are unable to induce
GD3 accumulation after Fas cross-linking. They can, how-
ever, induce GD3 by direct exposure to exogenous ceramides.
Together, these data indicated that GD3 accumulation that
follows Fas cross-linking requires ceramides derived from
the ASM, and strongly suggested that the ASM defect is re-
sponsible for the inability to accumulate GD3 and undergo
apoptosis efficiently after Fas cross-linking.
 
Restoring the ASM Defect Reinstates an Efficient Apoptotic
Program.
 
To prove that the ASM defect was indeed re-
sponsible for the inefficient apoptotic program, we at-
tempted to reconstitute both basal and inducible ASM ac-
tivities in NPD lymphoblasts. To accomplish this aim we
took advantage of a clone of CHO cells stably expressing a
secreted functional ASM (20). CHO-18 cells secrete ASM
in the supernatant, which is therefore enriched in func-
tional ASM. NPD lymphoblasts cultured for 24 h in the
presence of 25% CHO-18 culture supernatant, but not
wild-type CHO culture supernatant, could essentially re-
cover a “normal” basal ASM activity (Fig. 4 
 
A
 
). NPD lym-
phoblasts internalize ASM through M6P receptor–medi-
ated endocytosis, since reconstitution is completely
inhibited by excess M6P (Fig. 4 
 
A
 
). ASM-treated NPD
lymphoblasts have basal ASM levels comparable to those of
normal lymphoblasts, and can also respond to Fas cross-
linking with an 
 
z
 
100% increase in ASM activity, as do
normal lymphoblasts (Fig. 4 
 
B
 
). No induction of ASM ac-
tivity in response to Fas cross-linking can be measured in
untreated NPD lymphoblasts or in NPD lymphoblasts
treated with ASM in the presence of excess M6P (Fig. 4 
 
B
 
).
Also, the kinetics of ASM induction in response to Fas
cross-linking in reconstituted NPD lymphoblasts is compa-
rable to that one observed in normal lymphoblasts (Fig. 4 
 
C
 
).
We therefore investigated whether Fas-deriving signals
in ASM-reconstituted NPD lymphoblasts were now able
to progress up to GD3 accumulation and efficiently trigger
apoptosis. Indeed, Fas cross-linking led to normal GD3 ac-
cumulation in ASM-reconstituted NPD lymphoblasts (Fig.
5 
 
A
 
). Accordingly, ASM-reconstituted lymphoblasts recov-
ered the ability to undergo apoptosis in response to Fas
cross-linking with a kinetics comparable to that observed in
normal lymphoblasts. Functional recovery was largely pre-
Figure 4. Exposure to exogenous ASM reconstitutes ASM activity in
NPD lymphoblasts. (A) ASM activity in NPD lymphoblasts cultivated in
complete medium alone (open columns), medium containing 25% of pa-
rental CHO cell supernatant (hatched columns), 25% CHO-18 supernatant
(shaded columns), or 25% CHO-18 supernatant in the presence of 3 mM
M6P (closed columns). (B) ASM activity in normal or NPD lymphoblasts
treated for 15 min with control IgM (open bars) or 500 ng/ml anti-Fas
(shaded bars). NPD cells were also preincubated for 24 h with 25% CHO-18
supernatant in the absence or in the presence of 3 mM M6P. Results rep-
resent mean 6 SD from four different experiments. Time course of ASM
activity in control (open triangles), anti-Fas stimulated (closed triangles) nor-
mal (C) or ASM-reconstituted NPD (D) lymphoblasts. A representative
experiment out of three performed is shown.
Figure 5. Reconstitution of ASM restores Fas-induced GD3 accumu-
lation and efficient apoptosis in NPD lymphoblasts. (A) NPD lymphoblasts
were preincubated for 24 h with CHO (2) or CHO-18 (ASM) superna-
tant and stimulated for 15 min with control IgM or 500 ng/ml anti-Fas,
or for 5 min with 100 mM C6-ceramide (cer). Then polar lipids were ex-
tracted, run on HPTLC plates along with GD3 standard (st), and GD3
was detected by anti-GD3 immunostaining. Three experiments gave
comparable results. (B) NPD lymphoblasts were incubated for 24 h with
or without ASM-containing medium, in the presence or in the absence of
3 mM M6P, and stimulated for different time points with 200 ng/ml anti-
Fas or control IgM. The percentage of apoptotic cells was evaluated by
propidium iodide staining and flow cytometry analysis of cell nuclei.
Mean values and standard deviations at each time point, from four differ-
ent experiments are shown.901 De Maria et al.
vented by excess M6P, which also prevented the reconsti-
tution of ASM activity (Fig. 5 B).
Concluding Remarks. Here we show that ASM is re-
quired for GD3 ganglioside accumulation in response to
Fas cross-linking and efficient apoptosis in lymphoid cells.
Previous observations indicated that ASM was part of a
lipid pathway originating from the “death domains” of re-
ceptors belonging to the TNF-R family (10, 21). This
pathway was shown to be responsible for the generation of
ceramides relevant for Fas-induced cell death (8, 10, 22).
Direct genetic evidence also indicated that the ASM defect
is responsible for significant protection from radiation-
induced apoptosis in NPD-derived human fibroblasts or in
mice where the ASM gene has been disrupted by gene tar-
geting (19). Here we reconstituted an efficient Fas-induced
apoptotic program in ASM-deficient lymphoblasts by di-
rect ASM replacement. Our data suggest that ASM-derived
ceramides are used for ganglioside biosynthesis, up to the
generation of GD3 ganglioside. GD3 is a key effector mol-
ecule of the lipid pathway, being extremely effective in in-
ducing membrane permeability changes in mitochondria
(11). In fact, preventing ganglioside biosynthesis and GD3
accumulation in lymphocytes significantly protects from
Fas-derived apoptotic signals (11). ASM activation and
GD3 accumulation are therefore tightly linked steps along
the same pathway. Since ASM is activated within minutes
from Fas cross-linking, ASM-deriving ceramides, and the
resultant GD3, probably play a role in the initial stages of
the apoptotic program, most likely in the early damage to
mitochondria (Rippo, M.R., et al., manuscript submitted
for publication). Subsequent activation of cytosolic NSM is
then responsible for massive ceramide accumulation, cru-
cially contributing to the apoptotic process during the fol-
lowing hours (15, 16). The data presented here indicate
that ASM activation is critical for the optimal progression
of early apoptotic signals originating from Fas in lymphoid
cells.
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